Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


PHOENIX BIOTECH ACQUISITION CORP. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/19/2023 S-4/A Form S-4/A - Registration of securities, business combinations: [Amend]
07/18/2023 425 Form 425 - Prospectuses and communications, business combinations:
07/18/2023 8-K/A Quarterly results
07/10/2023 425 Form 425 - Prospectuses and communications, business combinations:
07/10/2023 8-K Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submiss...
Docs: "Second Amendment to the Amended and Restated Certificate of Incorporation of Phoenix Biotech Acquisition Corp",
"Amendment No. 2 to the Investment Management Trust Agreement, by and between the Company and Continental Stock Transfer & Trust Company, as trustee"
07/03/2023 425 Form 425 - Prospectuses and communications, business combinations:
07/03/2023 8-K Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "PROXY SUPPLEMENT, DATED JULY 3, 2023"
07/03/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
06/06/2023 S-4 Form S-4 - Registration of securities, business combinations:
05/19/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
02/14/2023 SC 13G/A GOLDMAN SACHS GROUP INC reports a 0% stake in PHOENIX BIOTECH ACQUISITION CORP.*
02/14/2023 SC 13G/A Beryl Capital Management LLC reports a 0% stake in Phoenix Biotech Acquisition Corp
02/14/2023 SC 13G/A Saba Capital Management, L.P. reports a 6.6% stake in Phoenix Biotech Acquisition Corp
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/27/2023 8-K Other Events  Interactive Data
01/25/2023 SC 13G/A HIGHBRIDGE CAPITAL MANAGEMENT LLC reports a 0% stake in Phoenix Biotech Acquisition Corp.
12/20/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Amendment to the Amended and Restated Certificate of Incorporation of Phoenix Biotech Acquisition Corp",
"Promissory Note, issued to Phoenix Biotech Sponsor, LLC",
"Amendment No. 1 to the Investment Management Trust Agreement, by and between the Company and Continental Stock Transfer & Trust Company, as trustee"
12/07/2022 425 Form 425 - Prospectuses and communications, business combinations:
12/07/2022 8-K Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  ...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Termination Agreement",
"Intrinsic Medicine and Phoenix Biotech Acquisition Corp. Mutually Agree to Terminate Business Combination Agreement Seattle, WA, December 6, 2022 — Intrinsic Medicine, Inc. , a therapeutics company leveraging human milk biology to transform Gut-Brain Axis and inflammatory disorders, and Phoenix Biotech Acquisition Corp. , a special purpose acquisition company sponsored by Phoenix Biotech Sponsor, LLC and formed for the purpose of acquiring or merging with one or more businesses, today announced the mutual termination of their previously announced business combination agreement due to current market conditions. “Intrinsic was encouraged by the positive feedback from prospective investors regarding the attractiveness of our novel and capital-efficient approach to developing transformative ne..."
11/21/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
11/04/2022 PRE 14A Form PRE 14A - Other preliminary proxy statements:
08/11/2022 10-Q Quarterly Report for the period ended June 30, 2022
05/13/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/06/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
03/24/2022 10-K Annual Report for the period ended December 31, 2021
02/14/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/08/2022 SC 13G PHOENIX BIOTECH SPONSOR, LLC reports a 23% stake in Phoenix Biotech Acquisition Corp.
11/19/2021 10-Q Quarterly Report for the period ended September 30, 2021
10/22/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/18/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/18/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/15/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy